Soyoung Kim, PhD

Publications

• Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.

  (Murthy GSG, Kim S, Estrada-Merly N, Abid MB, Aljurf M, Assal A, Badar T, Badawy SM, Ballen K, Beitinjaneh A, Cerny J, Chhabra S, DeFilipp Z, Dholaria B, Perez MAD, Farhan S, Freytes CO, Gale RP, Ganguly S, Gupta V, Grunwald MR, Hamad N, Hildebrandt GC, Inamoto Y, Jain T, Jamy O, Juckett M, Kalaycio M, Krem MM, Lazarus HM, Litzow M, Munker R, Murthy HS, Nathan S, Nishihori T, Ortí G, Patel SS, Van der Poel M, Rizzieri DA, Savani BN, Seo S, Solh M, Verdonck LF, Wirk B, Yared JA, Nakamura R, Oran B, Scott B, Saber W.) Haematologica. 2023 Feb 09 PMID: 36779595 02/14/2023

• The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.

  (Mei M, Pillai R, Kim S, Estrada-Merly N, Afkhami M, Yang L, Meng Z, Abid MB, Aljurf M, Bacher U, Beitinjaneh A, Bredeson C, Cahn JY, Cerny J, Copelan E, Cutler C, DeFilipp Z, Diaz Perez MA, Farhadfar N, Freytes CO, Gadalla SM, Ganguly S, Gale RP, Gergis U, Grunwald MR, Hamilton BK, Hashmi S, Hildebrandt GC, Lazarus HM, Litzow M, Munker R, Murthy HS, Nathan S, Nishihori T, Patel SS, Rizzieri D, Seo S, Shah MV, Solh M, Verdonck LF, Vij R, Sobecks RM, Oran B, Scott BL, Saber W, Nakamura R.) Haematologica. 2023 Jan 01;108(1):150-160 PMID: 35443559 PMCID: PMC9827167 SCOPUS ID: 2-s2.0-85145425537 04/22/2022

• The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study.

  (Ramanathan M, Kim S, He N, Chen M, Hematti P, Abid MB, Rotz SJ, Williams KM, Lazarus HM, Wirk B, Yin DE, Kanakry CG, Perales MA, Chemaly RF, Dandoy CE, Riches M, Ustun C.) Bone Marrow Transplant. 2022 Dec 21 PMID: 36543999 12/22/2022

• Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.

  (Feurstein S, Trottier AM, Estrada-Merly N, Pozsgai M, McNeely K, Drazer MW, Ruhle B, Sadera K, Koppayi AL, Scott BL, Oran B, Nishihori T, Agrawal V, Saad A, Lindsley RC, Nakamura R, Kim S, Hu Z, Sobecks R, Spellman S, Saber W, Godley LA.) Blood. 2022 Dec 15;140(24):2533-2548 PMID: 35969835 PMCID: PMC9918848 SCOPUS ID: 2-s2.0-85143522737 08/16/2022

• Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.

  (Olson TS, Frost BF, Duke JL, Dribus M, Xie HM, Prudowsky ZD, Furutani E, Gudera J, Shah YB, Ferriola D, Dinou A, Pagkrati I, Kim S, Xu Y, He M, Zheng S, Nijim S, Lin P, Xu C, Nakano TA, Oved JH, Carreno BM, Bolon YT, Gadalla SM, Marsh SG, Paczesny S, Lee SJ, Monos DS, Shimamura A, Bertuch AA, Gragert L, Spellman SR, Babushok DV.) JCI Insight. 2022 Nov 22;7(22) PMID: 36219480 PMCID: PMC9746824 SCOPUS ID: 2-s2.0-85143530400 10/12/2022

• Marginal semiparametric transformation models for clustered multivariate competing risks data.

  (He Y, Kim S, Mao L, Ahn KW.) Stat Med. 2022 Nov 20;41(26):5349-5364 PMID: 36117139 PMCID: PMC9650627 SCOPUS ID: 2-s2.0-85138223278 09/19/2022

• Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis.

  (Dholaria B, Radujkovic A, Estrada-Merly N, Sirait T, Kim S, Hernández-Boluda JC, Czerw T, Hayden PJ, Kansagra A, Ho VT, Nishihori T, Shaughnessy P, Scott B, Nakamura R, Oran B, Kharfan-Dabaja M, Savani BN, McLornan D, Yakoub-Agha I, Saber W.) Br J Haematol. 2022 Aug;198(4):785-789 PMID: 35658101 PMCID: PMC9750039 SCOPUS ID: 2-s2.0-85131178650 06/04/2022

• Competing risks regression models with covariates-adjusted censoring weight under the generalized case-cohort design.

  (Xu Y, Kim S, Zhang MJ, Couper D, Ahn KW.) Lifetime Data Anal. 2022 Apr;28(2):241-262 PMID: 35034255 PMCID: PMC8977245 SCOPUS ID: 2-s2.0-85123103100 01/17/2022

• A calibrated Bayesian method for the stratified proportional hazards model with missing covariates.

  (Kim S, Kim JK, Ahn KW.) Lifetime Data Anal. 2022 Apr;28(2):169-193 PMID: 35034213 PMCID: PMC8977246 SCOPUS ID: 2-s2.0-85123120385 01/17/2022

• Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

  (Guru Murthy GS, Kim S, Hu ZH, Estrada-Merly N, Abid MB, Aljurf M, Bacher U, Badawy SM, Beitinjaneh A, Bredeson C, Cahn JY, Cerny J, Diaz Perez MA, Farhadfar N, Gale RP, Ganguly S, Gergis U, Hildebrandt GC, Grunwald MR, Hashmi S, Hossain NM, Kalaycio M, Kamble RT, Kharfan-Dabaja MA, Hamilton BK, Lazarus HM, Liesveld J, Litzow M, Marks DI, Murthy HS, Nathan S, Nazha A, Nishihori T, Patel SS, Pawarode A, Rizzieri D, Savani B, Seo S, Solh M, Ustun C, van der Poel M, Verdonck LF, Vij R, Wirk B, Oran B, Nakamura R, Scott B, Saber W.) JAMA Oncol. 2022 Mar 01;8(3):404-411 PMID: 35024768 PMCID: PMC8759031 SCOPUS ID: 2-s2.0-85123085547 01/14/2022

• The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR study

  (Ramanathan M, Kim S, He N, Chen M, Hematti P, Abid MB, Rotz SJ, Williams KM, Lazarus HM, Wirk B, Yin DE, Kanakry CG, Perales MA, Chemaly RF, Dandoy CE, Riches M, Ustun C.) Bone Marrow Transplantation. 2022 SCOPUS ID: 2-s2.0-85144532838 01/01/2022

• Correction: Case-cohort design in hematopoietic cell transplant studies.

  (Cai J, Kim S.) Bone Marrow Transplant. 2022 Jan;57(1):145 PMID: 34857916 SCOPUS ID: 2-s2.0-85120652012 12/04/2021